A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib
Clinical trial NCT03627754 · COMPLETED
Trial details
- NCT number
- NCT03627754
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-05
- Primary completion
- 2019-04-11
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.